What does BBIBP-CORV mean in PRODUCTS
BBIBP-CorV (Beijing Bio-Institute of Biological Products Coronavirus Vaccine) is an inactivated virus vaccine developed by the Beijing Bio-Institute of Biological Products Co., Ltd. (BBIBP) to combat the COVID-19 pandemic. The vaccine is manufactured using inactivated SARS-CoV-2 virus particles, which are no longer infectious but still stimulate the immune system to produce antibodies and immune cells that protect against future infection.
BBIBP-CorV meaning in Products in Business
BBIBP-CorV mostly used in an acronym Products in Category Business that means Beijing Bio-Institute of Biological Products Coronavirus Vaccine
Shorthand: BBIBP-CorV,
Full Form: Beijing Bio-Institute of Biological Products Coronavirus Vaccine
For more information of "Beijing Bio-Institute of Biological Products Coronavirus Vaccine", see the section below.
Key Features
- Inactivated Virus Vaccine: Contains inactivated SARS-CoV-2 virus particles, rendering them non-infectious while preserving their immunogenic properties.
- Two-Dose Regimen: Administered in two doses, typically 2-4 weeks apart, to induce robust immunity.
- Widely Accessible: Produced on a large scale, making it available to a wide population globally.
- Stable and Easy to Store: Can be stored at standard refrigeration temperatures, facilitating distribution and logistics.
Efficacy and Safety
Phase III clinical trials have demonstrated the following efficacy and safety profile for BBIBP-CorV:
- Preventive Efficacy: >85% protective against symptomatic COVID-19, with high efficacy against severe disease and hospitalization.
- Long-Lasting Immunity: Antibody levels remain high for at least six months after vaccination, providing sustained protection.
- Minimal Side Effects: Common side effects include mild pain at the injection site, fever, and headache, which typically resolve within a few days.
Usage and Distribution
BBIBP-CorV has been authorized for emergency use in over 60 countries worldwide, including China, Brazil, Chile, Indonesia, and Mexico. It is primarily used in vaccination campaigns targeting healthcare workers, high-risk individuals, and the general population.
Essential Questions and Answers on Beijing Bio-Institute of Biological Products Coronavirus Vaccine in "BUSINESS»PRODUCTS"
What is BBIBP-CorV?
BBIBP-CorV is an inactivated virus vaccine developed by the Beijing Bio-Institute of Biological Products and approved for emergency use against COVID-19.
How does BBIBP-CorV work?
BBIBP-CorV contains inactivated SARS-CoV-2 virus particles, which cannot cause infection but stimulate the immune system to recognize and develop antibodies and immune cells against the virus.
Is BBIBP-CorV safe?
Clinical trials have shown BBIBP-CorV to be safe and well-tolerated. Common side effects include mild pain at the injection site, fever, headache, and muscle aches.
How effective is BBIBP-CorV?
Studies have shown that BBIBP-CorV is highly effective in preventing symptomatic COVID-19 infection, with an efficacy rate of around 79-85%.
How many doses of BBIBP-CorV are recommended?
BBIBP-CorV is administered in two doses, spaced 2-4 weeks apart.
Who is eligible to receive BBIBP-CorV?
BBIBP-CorV is generally recommended for adults aged 18 years or older. However, eligibility may vary depending on country-specific regulations.
Are there any contraindications for BBIBP-CorV?
BBIBP-CorV is not recommended for individuals who have a history of severe allergic reactions to any component of the vaccine. Additionally, individuals with certain medical conditions or who are immunocompromised may require special considerations.
Final Words: BBIBP-CorV is an effective and widely accessible inactivated virus vaccine that has contributed significantly to the global response to the COVID-19 pandemic. Its proven efficacy, safety, and ease of storage make it a valuable tool for protecting populations against SARS-CoV-2 infection, reducing the burden of severe disease, and ultimately returning to normalcy.
